IART - Integra LifeSciences Holdings Corporation
About Integra LifeSciences Holdings Corporation (https://www.integralife.com)
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Mojdeh Poul | President, Chief Executive Officer & Director | 1963 | $1,905,673 USD |
| Michael J. McBreen | Chief Commercial Officer | 1966 | $942,931 USD |
| Lea Daniels Knight | Executive Vice President & Chief Financial Officer | 1973 | $884,701 USD |
| Robert T. Davis Jr. | Executive Vice President & President of Tissue Technologies | 1959 | $722,354 USD |
| Harvinder Singh | Executive Vice President & President of International Business | 1966 | $714,613 USD |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer & Secretary | 1971 | $549,518 USD |
| Jeffrey Mosebrook | Senior Vice President of Finance & Principal Accounting Officer | 1976 | $493,138 USD |
| Stuart Essig | CEO, President & Chairman | 1962 | $85,000 USD |
| Chantal Veillon-Berteloot | Executive Vice President & Chief Human Resources Officer | 1971 | – |
| Christopher Ward | Senior Director of Investor Relations | – | – |
| Jessica Smith | Corporate VP & Global Quality and Chief Regulatory Officer | – | – |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations | – | – |
| Teshtar Elavia | Corporate VP & Chief Technology Officer | – | – |